Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Sevikar HCT
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Sevikar HCT 40mg/10mg/25mg tablets
0205052ACBBAEAE
|
Sevikar HCT | Olmesartan medoxomil/amlodipine/hydrochlorothiazide | Cardiovascular System | 1,643 |
|
Sevikar HCT 20mg/5mg/12.5mg tablets
0205052ACBBAAAA
|
Sevikar HCT | Olmesartan medoxomil/amlodipine/hydrochlorothiazide | Cardiovascular System | 743 |
|
Sevikar HCT 40mg/10mg/12.5mg tablets
0205052ACBBACAC
|
Sevikar HCT | Olmesartan medoxomil/amlodipine/hydrochlorothiazide | Cardiovascular System | 732 |
|
Sevikar HCT 40mg/5mg/12.5mg tablets
0205052ACBBABAB
|
Sevikar HCT | Olmesartan medoxomil/amlodipine/hydrochlorothiazide | Cardiovascular System | 503 |
|
Sevikar HCT 40mg/5mg/25mg tablets
0205052ACBBADAD
|
Sevikar HCT | Olmesartan medoxomil/amlodipine/hydrochlorothiazide | Cardiovascular System | 374 |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.